← Leaderboards
Paul J. Campagnola
University Of Connecticut Sch Of Med/Dnt
$5,220,412
Attributed
$10,552,112
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,552,112 · 11
By mechanism
R01$9,064,733 · 6
R21$872,592 · 3
R61$614,787 · 1
P30$0 · 1
Top collaborators
- Kevin William Eliceiri6 shared
- Pamela K Kreeger6 shared
- Kristyn S Masters6 shared
- Manish S Patankar6 shared
- Patricia J Keely5 shared
- Michael J Szulczewski5 shared
- Filiz Yesilkoy3 shared
- Nathan K Sandbo2 shared
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Mina Mina$12,290,005
Others in their field
Top investigators on “Collagen”
- Gary K Owens · University Of Virginia$22,073,978
- Billy Gerald Hudson · Vanderbilt University Medical Center$19,036,330
- Ravinder R Regatte · New York University School Of Medicine$18,437,784
- Brendan Hl Lee · Baylor College Of Medicine$16,945,312
- David E Harrison · Jackson Laboratory$16,731,987
- J. Edwin Blalock · University Of Alabama At Birmingham$16,139,060
Research focus
CollagenTissuesImageSecond HarmonicGenerationsTumorExtracellular MatrixBaseBiologicalArchitectureNeoplasm MetastasisIn VivoResolutionBiomimeticsStructureIn VitroMorphologySecond Harmonic Generation ImagingMalignant NeoplasmsDiagnosisSurvival RateInsightFiberMalignant Neoplasm Of Ovary
Grant awards (34)
A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches.$208,402
R61 · FY2025 · CA · contact PI
A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches.$197,983
R61 · FY2024 · CA · contact PI
A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches.$208,402
R61 · FY2023 · CA · contact PI
Engineered ECM platforms to analyze progression in high grade serous ovarian cancer$543,106
R01 · FY2022 · CA
Engineered ECM platforms to analyze progression in high grade serous ovarian cancer$57,513
R01 · FY2022 · CA
Engineered ECM platforms to analyze progression in high grade serous ovarian cancer$425,419
R01 · FY2021 · CA
Engineered ECM platforms to analyze progression in high grade serous ovarian cancer$491,592
R01 · FY2020 · CA
Quantitative assessment of the role of collagen alterations in ovarian cancer$447,811
R01 · FY2020 · CA · contact PI
Engineered ECM platforms to analyze progression in high grade serous ovarian cancer$436,446
R01 · FY2019 · CA
Quantitative assessment of the role of collagen alterations in ovarian cancer$377,861
R01 · FY2019 · CA · contact PI
3D biomimetic image-based stromal models of pancreatic cancer for drug screening$158,677
R21 · FY2019 · CA · contact PI
Quantitative assessment of the role of collagen alterations in ovarian cancer$61,961
R01 · FY2019 · CA · contact PI
Engineered ECM platforms to analyze progression in high grade serous ovarian cancer$436,391
R01 · FY2018 · CA
Quantitative assessment of the role of collagen alterations in ovarian cancer$389,549
R01 · FY2018 · CA · contact PI
3D biomimetic image-based stromal models of pancreatic cancer for drug screening$213,829
R21 · FY2018 · CA · contact PI
Quantitative assessment of the role of collagen alterations in ovarian cancer$418,598
R01 · FY2017 · CA · contact PI
Quantitative assessment of the role of collagen alterations in ovarian cancer$387,549
R01 · FY2016 · CA · contact PI
Second Harmonic Generation analysis of the ECM in idiopathic pulmonary fibrosis$182,770
R21 · FY2016 · HL · contact PI
Second Harmonic Generation analysis of the ECM in idiopathic pulmonary fibrosis$218,370
R21 · FY2015 · HL · contact PI
Development of The Prairie Technologies MPLSM to image cancer models in vivo$431,674
R01 · FY2013 · CA
Development of The Prairie Technologies MPLSM to image cancer models in vivo$459,893
R01 · FY2012 · CA
Development of The Prairie Technologies MPLSM to image cancer models in vivo$477,427
R01 · FY2011 · CA
Development of The Prairie Technologies MPLSM to image cancer models in vivo$494,615
R01 · FY2010 · CA
Development of The Prairie Technologies MPLSM to image cancer models in vivo$518,536
R01 · FY2009 · CA
Tissue protein imaging via second harmonic generaton$259,360
R01 · FY2006 · EB · contact PI
Tissue protein imaging via second harmonic generaton$265,204
R01 · FY2005 · EB
Tissue protein imaging via second harmonic generaton$336,047
R01 · FY2004 · EB
Tissue protein imaging via second harmonic generaton$473,921
R01 · FY2003 · EB
MULTIPHOTON BIOMEDICAL NANOFABRICATION$174,465
R01 · FY2003 · EB
MULTIPHOTON BIOMEDICAL NANOFABRICATION$166,692
R01 · FY2002 · EB
Second harmonic generation imaging microscopy$0
P30 · FY2002 · AR
MULTIPHOTON BIOMEDICAL NANOFABRICATION$197,343
R01 · FY2001 · GM
MULTIPHOTON BIOMEDICAL NANOFABRICATION$335,760
R01 · FY2000 · GM
NON LINEAR OPTICAL METHODS IN NEAR FIELD SCANNING$98,946
R21 · FY2000 · RR